Jefferies

Selected Jefferies Investment Banking Clients

Client Description & Recent Transactions

Bristol-Myers Squibb

Enterprise Value: $65 Billion

One of the largest pharmaceutical companies in the world

Recent Transactions
02/13 Sole advisor on $482 million collaboration agreement with Reckitt Benckiser Group plc for Latin American OTC products

BB&T

Enterprise Value: $20 Billion

One of  the largest financial services holding companies in the US

Recent Transactions
11/12 Joint bookrunner on $500 million senior notes offering

Perrigo

Enterprise Value: $10 Billion

Largest manufacturer of OTC pharmaceutical products for the store brand market in the world

Recent Transactions
09/12 Sole advisor on $285 million acquisition of Sergeant’s Pet Care Products, Inc.

Hellenic Coca-Cola

Enterprise Value: $10 Billion

One of the largest bottlers and vendors of The Coca-Cola Company’s products in the world

Recent Transactions
10/12 Sole advisor on $9.8 billion voluntary share exchange offer with Coca-Cola HBC AG

United

Enterprise Value: $15 Billion

Highest traffic airline in the world

Recent Transactions
09/12 Joint bookrunner on $844 million bond offering

Novartis

Enterprise Value: $175 Billion

2nd largest pharmaceutical company in the world

Recent Transactions
05/12 Sole financial advisor on $1.5 billion acquisition of Fougera Pharmaceuticals

Encana

 Enterprise Value: $20 Billion

2nd largest North American natural gas producer

Recent Transactions
04/12 Joint advisor on $607 million sale of royalty interest in Canadian CBM assets to Toyota Tsusho Corp.
02/12 Joint advisor on $2.9 billion sale of 40% interest in Cutbank Ridge Partnership to Mitsubishi Corporation

Vodafone

Enterprise Value: $180 Billion

One of the world's largest mobile communications companies by revenue

Recent Transactions
05/12 Sole advisor on sale of Vodacom's Gateway Carrier Services division to PCCW Global Ltd.

Reliance

Enterprise Value: $55 Billion

Largest public company in India

Recent Transactions
09/10 Lead advisor on $392 million acquisition of 60% stake in acreages held by Carrizo Oil & Gas

Pfizer

 Enterprise Value: $180 Billion

Largest pharmaceutical company in the world

Recent Transactions
01/13 Joint bookrunner on $2.6 billion initial public offering of Zoetis
10/12 Sole advisor on $700 million acquisition of option to acquire NextWave
08/10 Sole advisor on $655 million acquisition of FoldRx Pharmaceuticals

Thomson Reuters

 Enterprise Value: $30 Billion

Leading global provider of intelligent information for businesses and professionals

Recent Transactions
05/11 Sole financial advisor on acquisition of World-Check for undisclosed amount

AMR

 Enterprise Value: $25 Billion

Operator of one of the top five airlines in the world

Recent Transactions
12/11 Financial advisor to Association of Professional Flight Attendants on $24.7 billion restructuring

Siemens

Enterprise Value: $100 Billion

One of the world’s largest integrated technology companies

Recent Transactions
08/10 Sole advisor on sale of Roke Manor Research Limited to Chemring Group Plc

Chesapeake Energy

 Enterprise Value: $35 Billion

2nd largest producer of U.S. natural gas and the leader in developing natural gas shales

Recent Transactions
02/13 Joint advisor on $1.0 billion Mississippi Lime Joint Venture with Sinopec
12/12 Joint financial advisor on $2.2 billion sale of Chesapeake Midstream Development to Access Midstream Partners
11/12 Joint lead arranger on $2.0 billion credit facility
09/12 Joint advisor on $3.3 billion sale of Permian Basin assets to Royal Dutch Shell, Chevron and EnerVest Energy
09/12 Joint advisor on $2.7 billion sale of midstream assets to Global Infrastructure Partners

 First Quantum Minerals Ltd.

Enterprise Value: $10 Billion

Leading global independent copper producer

Recent Transactions
12/12 Joint advisor on $5.1 billion acquisition of Inmet Mining Corporation
10/12 Joint bookrunner on $350 million senior notes offering
01/12 Joint advisor in the $1.3 billion sale of assets in the Democratic Republic of Congo  to Eurasian Natural Resources 

 Baxter

 Enterprise Value: $40 Billion

Largest global provider of medical products to the hospital market

Recent Transactions 
04/11 Sole advisor on $338 million acquisition of Prism Pharmaceuticals

 Statoil

 Enterprise Value: $90 Billion

One of the world’s largest oil & gas companies and the largest gas company in Western Europe

Recent Transactions
05/10 Sole advisor in the $3.1 billion sale of 40% stake in Peregrino field to Sinochem Group

 Ventas

Enterprise Value: $25 Billion

8th largest REIT in the world

Recent Transactions
12/12 Joint bookrunner on $225 million senior notes offering
10/10 Lead advisor in the $3.1 billion acquisition of real estate assets from Atria Senior Living Group 

 Kodak

Enterprise Value: $5 Billion

Leading provider of products and services to the global photographic, film and graphic communications markets

Recent Transactions
01/12 Financial advisor to Official Committee of Unsecured Creditors on $4.6 billion restructuring

BP

Enterprise Value: $170 Billion

2nd largest super major oil company in the world by proved reserves

Recent Transactions
12/12 Sole advisor on $288 million pending sale of interest in the Sean field to SSE plc
11/12 Sole advisor on $1.1 billion (+$250 million in contingent payments) sale of Central North Sea Assets to TAQA
09/12 Sole advisor on $240 million sale of interests in the Draugen field to Royal Dutch Shell
06/12 Sole advisor on $280 million sale of interests in the Alba and Britannia Fields to Mitsui & Co., Ltd.

Valeant

Enterprise Value: $24 Billion

Leading specialty pharmaceutical company in the fields of dermatology and neurology

Recent Transactions
09/10 Joint lead arranger on $1.8 billion credit facility to finance merger with Biovail 
06/10 Joint financial advisor on $6.7 billion merger with Biovail Corp.

Williams Partners L.P.

Enterprise Value: $25 Billion

3rd largest diversified midstream MLP in the United States

Recent Transactions
03/13 Joint bookrunner on $636 million common unit offering
08/12 Joint bookrunner on $503 million common unit offering
04/12 Joint bookrunner on $599 million common unit offering